TerrAscend (TSNDF) Total Current Liabilities (2021 - 2026)
TerrAscend (TSNDF) posted quarterly Total Current Liabilities of $67.7 million for Q1 2026, down 12.43% year-over-year from $77.3 million in Q1 2025, and down 15.33% quarter-over-quarter from $79.9 million in Q4 2025.
TerrAscend (TSNDF) Total Current Liabilities (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has reported Total Current Liabilities for 6 consecutive years, with $67.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Current Liabilities fell 12.43% year-over-year to $67.7 million; the TTM figure through Mar 2026 stood at $67.7 million (down 12.43% YoY), while the FY2025 annual figure was $79.9 million, down 12.21% from the prior year.
- Total Current Liabilities retreated to $67.7 million in Q1 2026 per TSNDF's latest filing, from $79.9 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $207.0 million in Q4 2023 and bottomed at $67.7 million in Q1 2026.
- Historically, Total Current Liabilities has averaged $122.4 million across 5 years, with a median of $133.5 million in 2023.
- Annual changes were most pronounced in 2022 — Total Current Liabilities soared 108.36% — and 2025, when it slumped 61.18%.
- TerrAscend's Total Current Liabilities stood at $137.9 million in 2022, then jumped by 50.1% to $207.0 million in 2023, then sank by 56.01% to $91.0 million in 2024, then declined by 12.21% to $79.9 million in 2025, then retreated by 15.33% to $67.7 million in 2026.
- Business Quant data shows TSNDF's Total Current Liabilities at $67.7 million in Q1 2026, $79.9 million in Q4 2025, and $76.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -8.38 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 15.65 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 2.06 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 17.34 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 607.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 6.35 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 874.50 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.85 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 1.79 Bn |
| 10 | TerrAscend | 182.53 Mn | 140.41 Mn | 36.25 Mn | 62.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 62.00 Mn |
| Mar 31, 2026 | 67.68 Mn |
| Dec 31, 2025 | 79.93 Mn |
| Sep 30, 2025 | 76.31 Mn |
| Jun 30, 2025 | 91.66 Mn |
| Mar 31, 2025 | 77.29 Mn |
| Dec 31, 2024 | 91.05 Mn |
| Sep 30, 2024 | 78.46 Mn |
| Jun 30, 2024 | 77.46 Mn |
| Mar 31, 2024 | 199.12 Mn |
| Dec 31, 2023 | 207.00 Mn |
| Sep 30, 2023 | 146.38 Mn |
| Jun 30, 2023 | 133.49 Mn |
| Mar 31, 2023 | 156.07 Mn |
| Dec 31, 2022 | 137.91 Mn |
| Sep 30, 2022 | 172.34 Mn |
| Jun 30, 2022 | 140.40 Mn |
| Mar 31, 2022 | 148.27 Mn |
| Dec 31, 2021 | 66.19 Mn |